Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

AGPCNP > Cancer Screening > Flashcards

Cancer Screening Flashcards

1
Q

Describe the carcinogenic pathway

A
  1. initiation
    - inherited acquired DNA change, immature response
  2. promotion
    - additional exposures, DNA mutations, epigenetic changes, immune response, pre-malignant dx, early malignant dx
  3. progression
    - additional exposures, DNA mutations, epigenetic changes, immune response, symptomatic dx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a risk factor?

A

characteristic associated with statistically significant likelihood of developing particular disease in a particular time
-risk increase with dose/exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Probability calculation

A
  • average v high risk individual (or group)

- use of multifactorial risk calculators, if available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are risk reduction interventions and why should/shouldn’t consider them?

A
  • goal is to decrease cancer susceptibility, stop carcinogenesis, ideally evidence-based, not available for all cancers, is the individual willing and or able to follow?
  • lifestyle modification, vaccination, chemoprevention, prophylactic surgeries
  • do benefits exceed risks? Accept more risk from interventions if individual or group is higher risk for disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What disease-specific characteristics are necessary to be considered for screening?

A

Early detection of sub-clinical disease
Asymptomatic
Disease
Be clinically relevant
High incidence, mortality, morbidity
Has an obvious pre-clinical stage before symptoms present
Has an effective treatment for early stage cancer
Improved outcome when treated at early stage
Shortening disease duration
Decreasing the severity of the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are screening test examples and what characteristics must they have?

A

Cheap, simple, safe, minimally invasive, widely available, culturally acceptable

Includes 
Imaging 
Laboratory tests
Exfoliative cytology 
Endoscopy 
Physical examinations 
Self examinations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What characteristics must a patient have to be considered for screening?

A

If positive
Likely to undergo treatment
Has access to care

Patients should know
primary risk reduction strategies
symptoms of cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are symptoms of cancer?

A 
unexplained weight loss
extreme fatigue
skin changes
nagging cough/hoarseness
lump thickening in breast
fever, night sweats
persistent pain
change in bowel/bladder
unusual bleeding/discharge
difficulty swallowing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are general screening recommendations for high risk patients?

A

Generally beginning screening earlier
FH but no genetic predisposition syndrome, start screening when patient 10 years YOUNGER than age affected family member diagnosed with cancer
Perform more often than for average risk patients
May do more invasive, riskier screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What considerations are there of screening older adults for cancer?

A

“Screening in the elderly is not associated with a survival advantage”

Elderly frequently have life limiting co-morbid medical conditions

More indolent nature of some cancers in the elderly
“Die with or die of cancer” conundrum

But studies have not always
Included older adults
Adjusted for differences in frailty
Accounted for groups at increased risk
Addressed impact of screening on QOL, suffering, or functionality

More likely to be diagnosed at advanced stage than younger counterparts
** Never screened **
Many will benefit from treatment
But with advanced stage, more extensive treatments
Aging population, increased cancer burden, costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Breast cancer lifetime risk

A

12.4%
age 40-70
median age 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Most common cancers based on sex

A
  • most likely to die, lung for both
  • prostate most likely “men”
  • breast most likely “women”
  • colon is next for both
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss family history and risk assessment for screening

A 
Family History
If 1st degree relative with cancer
Especially if diagnosed at younger age
generally start screening for that cancer 10 yrs before the age of affected person when diagnosed
Breast Cancer Family history
First degree relative: RR 2.5
Second degree relative: RR 1.5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Red flags for cancer predisposition syndromes

A

Cancer in 2 or more close relatives on
same side family
Early age at diagnosis
Multiple primaries in the same individual
Bilateral cancers
Constellation of tumors associated with a specific cancer syndrome (ie. breast and ovarian)
Presence of congenital anomalies or syndrome associated benign lesions

Family History
Paternal and maternal, 2-3 generations
Dynamic and evolve over time
De novo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss BRCA 1 lifetime risk

A

Breast cancer 50%-85% (often early age at onset)

Second primary breast cancer 40%-60%

Ovarian cancer 15-45%

Slightly increased risk of Uterine and Cervical cancer

Possible increased risk of other cancers:
Prostate Colon
Male breast cancer Fallopian tube
Pancreatic Gastric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss BRCA2 lifetime risk

A 
Breast Cancer 
(50%-85%)
Male Breast Cancer 
(6%)
Ovarian Cancer 
(10%-20%)
Increased risk of other cancers:
Prostate		Laryngeal
Pancreatic		Melanoma
Stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PMH/PSH risk for breast ca

A 
Benign breast disease 
Proliferative without atypia:  RR 1.5-2.0
Atypical hyperplasia: RR 4.0-5.0
Atypia with family history:  RR 11
Other cancers 
Especially breast, and ovarian
Previous therapeutic thoracic radiation therapy
2nd or 3rd decade - 56 fold increase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Reproductive risk factors for breast ca

A 
Early menarche (<9 years):  RR 1.2
Late menopause (>55 years):  RR 2.0
Full-term pregnancy (> 30 years of age):  RR 2.0
Nulliparity:  RR 1.4
HRT:  RR 2
OCP:  RR 0.9
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Social history risks for Breast ca

A

Obesity
Pre menopause: RR 0.6 - 1
Post Menopause: RR 1.16 - 1.74

ETOH
1-2/day: RR 1.04 - 1.19
2-4/day: RR 1.21 – 1.41

Smoking
Fruits/Vegetables
Exercise decrease risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Family history risk for breast ca

A

1st Degree: RR 2.5
2nd Degree: RR 1.5

Genetic predisposition syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the GAIL model for Breast cancer?

A

5 year and lifetime risk, in women >35 1.7% = high risk

includes: age, reproductive history, benign breast disease history, atypical hyperplasia, breast cancer in mother or sisters, race in modified model

does not include: other cancers, 2nd deg relatives, paternal history, age at diagnosis in relatives, modifiable risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the Claus Model?

A

Predictive model for breast cancer risk. predominantly based on family history (and number of family members) and age.
-20% or greater lifetime risk of breast cancer is high risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Breast cancer risk reduction for average risk patients

A
  1. lean healthy weight 18.5-25 BMI
  2. diet (plant based); men 12-1600, women 10-1200, lean protein
  3. 30 minutes exercise daily
  4. ETOH max 1 drink per day, CAGE
  5. reproductive
    - avoid/limit HRT, lowest dose, shortest time needed
  6. pregnancy
  7. breastfeeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Breast cancer risk reduction for high risk patients

A
  1. chemoprevention
    - tamoxifen (Nolvadex)
    - raloxifen (Evista)
  2. Preventive Sx
    - prophylactic mastectomy
    - prophylactic oopherectomy (35-40 age, upon completion of childbearing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Average risk mammogram recommendations
Mammography Regular, annually age 45-54 -biennial or annual >54 -opportunity for annual age 40-44 No age upper age limit – good health status, life expectancy >10 years Willing to have diagnostic and therapeutic procedures
26
What are the birads scores mean?
Category 0: need additional imaging evaluation Category 1: negative- no findings to comment on. Category 2: benign finding - finding not consistent with mammographic evidence of malignancy. Category 3: probably benign finding–short-term interval follow-up suggested to establish its stability over time. Category 4: suspicious abnormality–biopsy should be considered Category 5: highly suggestive of malignancy–appropriate action should be taken
27
Breast cancer screening high risk
Known or likely BRCA mutation carriers Untested but 1st degree relative w/ BRCA mutation Approximately 20% to 25% or greater lifetime risk of breast cancer Radiation to chest for Hodgkin disease between ages 10-30 Li-Fraumeni syndrome, Cowden syndrome, or Bannayan-Riley-Ruvalcaba syndrome, or have first-degree relatives with one of these syndromes Starting age 30 Annual mammogram Addition of annual MRI CBE
28
What are clinical presentations of breast cancer?
``` Painless lump in the breast: Solitary, unilateral mass Solid, irregular Non-mobile Stabbing or aching pain Less common symptoms are: nipple discharge, retraction, dimpling, inflammatory symptoms ```
29
What is the lifetime risk and median age of ovarian cancer?
1.3% | median age 62
30
Risk factors for developing ovarian cancer
``` Age 55-64 yrs Median Age is 63 Race Reproductive factors Nulliparity/Low parity Early Menarche (before 12) Late Menopause (after 50) Late Full-term Pregnancy (> 35) Infertility HRT > 5 years Protective: Use of OCPs >5 years 1st Pregnancy <25 Breast Feeding ``` PMH/PSH Breast Cancer Endometrial Cancer 10% Social history Obesity High Fat Diet Talcum Powder ``` Familial history 5% if 1 First Relative 7% if 2 First Relatives Hereditary cancer syndromes including: BRCA 1 – 15-45% BRCA 2 – 10-20% ``` Hereditary Non-Polyposis Colon Cancer Syndrome (HNPCC) 10-15%
31
Risk reduction for ovarian cancer for average risk people
lifestyle: pregnancy, breastfeeding, limit HRT, limit obesity OCP for chemoprevention
32
Risk reduction for ovarian cancer for high risk people
OCPS??? surgery? BSO TAH? (hysto?)
33
Ovarian cancer screening recs
Average risk: no recommendations High risk: 2 1st degree relatives, BRCA and HNPCC mutations Starting age 25 Pelvic exam Trans-vaginal ultrasound CA 125 Annual until childbearing completed or at least age 35 and undergo prophylactic bilateral oophorectomy (NIH Consensus Conference, JAMA 1994) Transvaginal and CA 125 at discretion of provider starting age 30-35 (NCCN)
34
Clinical presentations for ovarian cancer
``` Early Signs Daily Symptoms Lasting More Than a Few Weeks Abdominal Bloating Difficulty Eating or Early Satiety Urinary Urgency Pelvic or Abdominal Pain Increased Abdominal Size Pain During Intercourse Change in Bowel/Bladder Habits Indigestion, Dyspepsia Early Satiety Back Pain Palpable Adnexal Mass In Pre-Menopausal Women – 5% Represent Cancer In Post-Menopausal Women - Requires Surgical Exploration ``` ``` Late Signs Ascites Pleural Effusion Anorexia Nausea/Vomiting Masses Abdominal Pelvic Ovarian Omental ```
35
Uterine cancer risk factors
Lifetime risk 2.9% Age Median Age 61 Racial Caucasian - Highest Incidence Rising in African Americans and Hispanics African Americans - Higher Mortality Reproductive factors Nulliparous RR 2.5 Late Menopause (> 52 yrs.) RR 2.4 Obesity >50 lbs RR 10.0 >20-30 lbs RR 3.0 ``` PMH/PSH Endometrial Hyperplasia 50% Diabetes RR 2.7 HTN RR 1.5 Unopposed Estrogen RR 6.0 PCOS RR 3.0 Tamoxifen RR 2.2 Ovarian Cancer 5% Breast Cancer Pelvic Radiation 1-3% OCP Reduction ``` FH 1st degree relative RR 1.82 BRCA 1 – Small Increased Risk Hereditary Non-Polyposis Colon Cancer Syndrome (HNPCC) (40-60% chance)
36
Risk reduction for endometrial cancer for average risk
lifestyle - prevent obesity, prevent metabolic syndrome, diet, exercise, pregnancy OCPs Limit unopposed HRT
37
Risk reduction for high risk endometrial cancer
surgery - hysto - BSO
38
Endometrial cancer screening recs
At time of menopause, educate average and high risk women about risks and symptoms ``` Very high risk: known HNPCC mutation, substantial likelihood of having mutation Beginning age 35 Transvaginal ultrasound Endometrial biopsy Annually until TAH (? BSO) ``` Expert opinion
39
Clinical presentation of endometrial cancer
Post-Menopausal Bleeding (>90%) Only 5-20% Have Endometrial Cancer Bleeding MUST BE WORKED UP for Cancer Longer Time Period Since Menopause = Higher Risk Pyometria Abnormal Cervical Cytology (Direct Extension) Pain Lumbosacral Hypogastric Pelvic Unexplained Weight Loss Change in Bowel/Bladder Habits
40
Prostate cancer risk factors
``` Lifetime risk approx 11.2% Age Median age 66 Race African American Highest Incidence & Mortality RR 1.8 PMH/PSH Other Cancers (?GU) FH One 1st Degree Relative > 2 Fold Risk 2 or 3 1st Degree Relatives 5 to 11 Fold Risk BRCA (Especially 2) HNPCC SH Vitamin E Agent Orange ```
41
Prostate Ca risk reduction, average risk
Unknown????
42
Prostate Ca high risk risk reduction
NO VITAMIN E, SELENIUM, DM -5 alpha reductase inhibitor (ie finasteride) 50% decrease in PC
43
ACS prostate cancer screening guidelines
Asymptomatic men with a >10 year life expectancy PSA should be discussed, beginning at: 50 average risk Men with hypogonadism, should have DRE 45 high risk (PSA and DRE) 1st degree relative diagnosed < 65, African American’s . 40 higher risk (PSA and DRE) Multiple 1st degree relatives diagnosed < 65 If abnormal DRE (size, symmetry, nodule) Refer to urology for biopsy If PSA <2.5, can repeat every 2 years >2.5, repeat annually 2.5 -4.0 consider referral to urology for biopsy if high risk (e.g. AA, FHX, increasing age) PSA > 4.0, generally refer for biopsy if average risk
44
Talk about PSA results and what they mean/risk for prostate cancer
Not prostate cancer specific Total PSA ~22% of men with PSA 2.5 -4 will have PC 30% of men with PSA >4 will have PC 67% of men with PSA >10 will have PC PSA velocity - Rate of change over time 0. 35 ng/mL/year increase in PSA <4 0. 75 ng/mL/year in PSA 4-10 Age, Prostatitis, sexual activity, DRE, bike riding, finesteride, saw palmetto
45
Talk about Free PSA
Free PSA - More PSA bound to protein in prostate cancer - % of free PSA is lower in prostate cancer is %free 0-10%, biopsy free 10-15% consider biopsy 15-20% 20% chance cancer
46
What is the clinical presentation of PC?
``` Localized Disease Symptoms May Mimic Symptoms of BPH or UTI Advanced Disease Bone Pain Pelvic Pain Fatigue LUTS Lymphadenopathy Since Availability and Application of PSA, Most Patients are Asymptomatic at Presentation! ```
47
Lung cancer risk
``` lifetime risk 6.2% median age at diagnosis is 70 Smoking—>80% of cases -Active -Passive Occupational/environmental carcinogens -Asbestos, radon, arsenic, air pollutants Family history Dietary deficiencies COPD History of lung cancer/other aerodigestive cancers ```
48
Risk reduction for lung cancer
Smoking cessation ETS Occupational Chemoprevention -No studies to date have identified any effective agents -Beta carotene supplements increased the risk of lung cancer in one study
49
ACD lung cancer screening recs
Ages 55 -74 Current and former (quit within last 15 years) heavy smokers (30 ppy) General health exclusions: Metallic implants or devices in the chest or back Requirement for home O2 Prior history of lung cancer or other lung cancer symptoms Willing to undergo diagnostic and curative therapies Annual LDCT at high volume lung centers Smoking cessation
50
Clinical manifestations of lung cancer
``` Cough—most commonly presenting symptom Dyspnea Chest pain Hoarseness Pain Fatigue Anorexia/Cachexia ```
51
Risk for colon cancer
Lifetime risk 4.2% Median age at dx 67 Risk increases with age 91% new colon cancer cases occur in patients over age 50 Risk increases with a personal or family history of colon cancer, polyps or inflammatory bowel disease Inherited genetic syndromes Familial adenomatous polyposis (FAP) Hereditary nonpolyposis colon cancer (HNPCC)
52
Discuss FAP
Familial Adenomatous Polyposis Syndrome (FAP) ``` APC Gene Colorectal Cancer Epidermoid Cysts Osteomas Desmoid Tumors CHRPE ```
53
Discuss HNPCC
Hereditary Non-Polyposis Colon Cancer Syndrome (HNPCC) MSH2, MLH1, PMS1, PMS2, MSH6 Increased Risk of Colorectal Cancer Increased Risk of Gastric Cancer 40-60% Chance of Developing Endometrial Cancer 10-15% Chance of Developing Ovarian Cancer "Lynch Syndrome"
54
What are modifiable risk factors for colon cancer?
``` Obesity (BMI >30) Diet high in fat Diet high in red meat (> 7 servings/week) Diet high in processed foods Diet low in fruits and vegetables Alcohol consumption (>1 drink/day) Smoking Physical Inactivity ASA ```
55
What does the colorectal GAIL risk assessment tool look at, and what does it neglect?
used: age 50-85, AA, asian american, pacific islander, hispanic/latino, white can not be used: american indians, IBD, HNPCC, FAP, personal history of CRC
56
CRC Risk reduction for average risk
``` Healthy Weight Physical Activity 30-60 Minutes/Day of Moderate to Strenuous Activity 5 or More Fruits and Vegetables/Day Whole Grains Limit Red Meats Don’t Smoke ```
57
CRC risk reduction for high risk
Chemoprevention ASA NSAIDS Cox 2 Inhibitors Prophylactic Surgery Colectomy
58
Cancer risks in HNPCC
``` CRC 82% endometrial 60% stomach 13% ovarian 12% urinary tract 7% biliary tract 2% ```
59
When to screen with FAP
Begin at puberty | Early surveillance with endoscopy and counseling to consider genetic testing
60
When to screen with HNPCC
begin age 21 | Colonoscopy and counseling to consider genetic counseling
61
When to screen with Inflammatory bowel disease Chronic ulcerative colitis Chrohn’s disease
Cancer risk begins to be significant 8 years after the onset of pancolitis, or 12-15 y after the onset of left-sided colitis Colonoscopy with biopsies for dysplasia
62
Cervical cancer risk factors
Age Mean Age 45-50 Peaks at 35-39 and 60-64 Race Lifestyle More Sexual Partners No Condoms Smoking ``` PMH/PSH: HPV STDs HIV DES Mothers ```
63
ACS cervical cancer screening recs
Even if HPV vaccinated 21-29 every 3 years with Pap tests. (HPV only if abnormal Pap) 30-65 every 5 years with Pap tests and HPV DNA test (preferred); OR every 3 years with Pap alone > 65 can stop if had 3 or more normal Pap tests or 2 consecutive negative HPV and Pap tests w/in last 10 years Total hysterectomy may stop screening History of CIN2 or CIN3 should continue to have testing for at least 20 years after the abnormality was found.
64
Cervical cancer screening with higher risk
DES exposure in utero Same protocol as average risk women < 30 years Continue with protocol >30 years Immunosuppressed HIV, Immunosuppressives for organ transplant, chronic corticosteroids, chemotherapy Screened twice during 1st year of diagnosis and annually there after No specific upper age to stop. Continue as long as in reasonably good health, likely to benefit from treatment
65
Clinical presentation of cervical cancer
``` Vaginal Bleeding Usually Post-coital Menorrhagia Vaginal Discharge Blood Tinged Bowel Obstruction Urinary Obstruction ```

AGPCNP (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions